Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1986 Feb;67(1):25–32.

Passive immunization of mice against Klebsiella aerogenes.

E A Roe, R J Jones, R E Dyster
PMCID: PMC2013063  PMID: 3511939

Abstract

Klebsiella vaccines were isolated by mild diafiltration techniques from culture filtrates of nine capsular types of K. aerogenes (K1, K2, K3, K15, K20, K35, K36, K44 & K63). The bacteria were grown in a chemically defined medium in standardized conditions in a fermenter. The vaccines had a molecular weight of more than 20 000, a carbohydrate content of 40-89%, a protein content of between less than 1 and 16% and small amounts (0.6-1.2%) of lipopolysaccharide. Antisera raised in rabbits to the nine klebsiella vaccines were standardized by passive haemagglutination, immunoglobulin G enzyme-linked immunosorbent assay and by autologous passive protection tests. Each rabbit antiserum when passively transferred to mice showed a variable capacity to passively protect mice against lethal infections by a panel of ten capsular types of K. aerogenes (K1-K10). Seven of the rabbit antisera protected mice against more than half of the challenge strains. A pool of six rabbit antisera (anti-K1, K2, K3, K20, K35 & K44) passively protected mice against lethal infections from strains of bacteria representing each of 77 capsular types of K. aerogenes.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryan C. S., Reynolds K. L., Brenner E. R. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 1983 Jul-Aug;5(4):629–638. doi: 10.1093/clinids/5.4.629. [DOI] [PubMed] [Google Scholar]
  2. Cryz S. J., Jr, Fürer F., Germanier R. Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide. Infect Immun. 1984 Jan;43(1):440–441. doi: 10.1128/iai.43.1.440-441.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis B., Lilly H. A., Lowbury E. J. Gram-negative bacilli in burns. J Clin Pathol. 1969 Nov;22(6):634–641. doi: 10.1136/jcp.22.6.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fukutome T., Mitsuyama M., Takeya K., Nomoto K. Importance of antiserum and phagocytic cells in the protection of mice against infection by Klebsiella pneumoniae. J Gen Microbiol. 1980 Jul;119(1):225–229. doi: 10.1099/00221287-119-1-225. [DOI] [PubMed] [Google Scholar]
  5. Gaffin S. L. Large-scale production of anti-gram-negative bacterial antibodies. Lancet. 1983 Dec 17;2(8364):1420–1421. doi: 10.1016/s0140-6736(83)90948-0. [DOI] [PubMed] [Google Scholar]
  6. Jones R. J. Passive immunisation against Gram-negative bacilli in burns. Br J Exp Pathol. 1970 Feb;51(1):53–58. [PMC free article] [PubMed] [Google Scholar]
  7. Jones R. J., Roe E. A. Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines. J Med Microbiol. 1984 Dec;18(3):413–421. doi: 10.1099/00222615-18-3-413. [DOI] [PubMed] [Google Scholar]
  8. Kreger B. E., Craven D. E., Carling P. C., McCabe W. R. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980 Mar;68(3):332–343. doi: 10.1016/0002-9343(80)90101-1. [DOI] [PubMed] [Google Scholar]
  9. Montgomerie J. Z., Ota J. K. Klebsiella bacteremia. Arch Intern Med. 1980 Apr;140(4):525–527. [PubMed] [Google Scholar]
  10. NICHOLLS P. The formation and properties of sulphmyoglobin and sulphcatalase. Biochem J. 1961 Nov;81:374–383. doi: 10.1042/bj0810374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pollack M. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J Infect Dis. 1983 Jun;147(6):1090–1098. doi: 10.1093/infdis/147.6.1090. [DOI] [PubMed] [Google Scholar]
  12. Riottot M. M., Fournier J. M., Jouin H. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun. 1981 Jan;31(1):71–77. doi: 10.1128/iai.31.1.71-77.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sponholtz D. K., Brautigan D. L., Loach P. A., Margoliash E. Preparation of cytochrome c2 from Rhodospirillum rubrum. Anal Biochem. 1976 May 7;72:255–260. doi: 10.1016/0003-2697(76)90528-5. [DOI] [PubMed] [Google Scholar]
  14. Ziegler E. J., McCutchan J. A., Fierer J., Glauser M. P., Sadoff J. C., Douglas H., Braude A. I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982 Nov 11;307(20):1225–1230. doi: 10.1056/NEJM198211113072001. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES